Spring Bank Pharmaceuticals to Present at Upcoming Investor Conferences

MILFORD, Mass., May 25, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, today announced that the Company will present at the following upcoming investor conferences:

  • The Marcum MicroCap Conference on Thursday, June 2, 2016, at 2:30 pm Eastern Time at the Grand Hyatt in New York City
  • The JMP Securities Life Sciences Conference on Tuesday, June 21, 2016, at 10:30 am Eastern Time at The St. Regis in New York City

Live audio webcasts of the presentations will be available on the company’s website at http://ir.springbankpharm.com. Replays of the webcasts will be available for 90 days.

About Spring Bank Pharmaceuticals

Spring Bank Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform. The company is developing its most advanced SMNH product candidate, SB 9200, for the treatment of viral diseases, including hepatitis B virus.

Investor Contact:
Spring Bank Pharmaceuticals, Inc.
Jonathan P. Freve
Chief Financial Officer
(508) 473-5993

Media Contact:
Argot Partners
Eliza Schleifstein

Source:Spring Bank Pharmaceuticals Inc.